Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals

ConditionPre Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-60
SponsorClinical Nutrition Research Center, Illinois Institute of Technology

About this trial

The purpose of this study is to investigate the effect of mango intake on metabolic and inflammatory responses relative to meals in individuals at risk of developing diabetes, as well as to understand how the beneficial compounds found in mangoes are absorbed and processed in the body.

Eligibility criteria

Qualifiers

Be between 20-60 years old.

Have a BMI of 25-35 kilograms per square meter.

Have fasting blood glucose between 100-125 milligrams per deciliter or Glycated hemoglobin (HbA1c) between 5.7-6.4%.

Be non-smokers for at least 12 months.

Disqualifiers

Smoke, vape, or use marijuana.

Have allergies or intolerance to mangoes or study foods.

Have blood pressure above 160/100 millimeters of Mercury.

Have fasting blood glucose above 125 milligrams per deciliter.

Trial design

Treatments tested in this trial

  • Mango
  • Control Beverage

Treatment groups

30 Participants
are divided into 4 treatment groups

Sponsors and collaborators